Benjamin Graham · Defensive deep-value investing
Is Ironwood Pharmaceuticals, Inc. (IRWD) a Benjamin Graham Stock?
Meets only 2/7 Graham criteria, likely overpriced or unstable.
25/100
Does not fit
2/7 criteria passed
Benjamin Graham's Criteria, Applied to IRWD
P/E ≤ 15
key4.5x
P/B ≤ 1.5
key-
Current ratio ≥ 2
1.4x
Debt / Equity ≤ 1
-
How IRWD Scores on Other Strategies
Live Financial Snapshot
Market cap
$598.17M
P/E (TTM)
4.5x
ROIC (TTM)
43.86%
Gross margin
99.75%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is IRWD's Benjamin Graham fit score?
IRWD scores 25/100 on our Benjamin Graham fit engine. Meets only 2/7 Graham criteria, likely overpriced or unstable.
Does Benjamin Graham actually own IRWD?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends IRWD.
How often is this score updated?
IRWD's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends IRWD.
